Evaluating clinical opinions on the efficacy and tolerability of a novel human milk oligosaccharide-based human milk fortifier containing lactoferrin, docosahexaenoic acid and arachidonic acid

Sanjay Wazir; Shelly Gupta

doi:10.18203/2349-3291.ijcp20243794

Authors

Sanjay Wazir Department of Neonatology, Motherhood Hospital, Gurugram, Haryana, India
Shelly Gupta Motherhood Hospital, Gurugram, Haryana, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20243794

Keywords:

Growth, Human milk fortifier, HMOs, Preterm babies

Abstract

Background: To gather and analyse the opinions of healthcare professionals regarding the effectiveness and tolerability of a novel human milk oligosaccharide (HMO)-based fortifier containing lactoferrin, docosahexaenoic acid (DHA) and arachidonic acid (ARA) in neonatal nutrition.

Methods: A cross-sectional survey was conducted among neonatologists and paediatricians who have utilised the novel HMO-based human milk fortifier (HMoF) in their clinical practice. Participants were asked to provide their feedback on various parameters including nutritional adequacy, growth outcomes, tolerance, and overall clinical efficacy.

Results: Majority of respondents reported positive outcomes in terms of enhanced growth parameters, improved gastrointestinal tolerance, and overall health of the infants. The fortifier was particularly noted for its role in supporting the overall growth of the infants including weight gain, length gain and head circumference gain due to the presence of HMOs, lactoferrin, DHA, and ARA.

Conclusions: The novel HMO-based human milk fortifier containing lactoferrin, DHA, and ARA has garnered a favourable and positive opinion by healthcare professionals and demonstrates potential benefits in enhancing neonatal nutrition and health outcomes.

Metrics

Metrics Loading ...

References

Rousseaux A, Brosseau C, Le Gall S, Piloquet H, Barbarot S, Bodinier M. Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. Front Immunol. 2021;12:680911.

Chaturvedi N, Gupta B, Sahrawat N, Dua S, Kumari C, Mittal S. Human Milk Oligosaccharides: Potential Upshot on Health at Early Life Stage Development. Nutr Food Sci. 2024;12(1):283-95.

Kell DB, Heyden EL and Pretorius E. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front Immunol. 2020;11:1221.

Carlotta C, Elisa B, Blanco Llamero C, Faezeh F, Oliveira MBPP, Krambeck K, et al. Biomedical and Nutritional Applications of Lactoferrin. Int J Peptide Res Therapeut. 2023;29(5):71.

Carlson SE, Colombo J. Docosahexaenoic Acid and Arachidonic Acid Nutrition in Early Development. Adv Pediatr. 2016;63(1):453-71.

Goehring KC, Marriage BJ, Oliver JS, Wilder JA, Barrett EG, Buck RH. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. J Nutr. 2016;146(12):2559-66.

Koletzko B, Lien E, Agostoni C, Böhles H, Campoy C, Cetin I, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

Ayechu-Muruzabal V, Van Stigt AH, Mank M, Willemsen LE, Stahl B, Garssen J, et al. Diversity of human milk oligosaccharides and effects on early life immune development. Front Pediatr. 2018;6:239.

Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, et al. Effects of infant formula with human milk oligosaccharides on growth and morbidity: A randomized multicenter trial. J Pediatr Gastroenterol Nutr 2017;64(4):624-31.

Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. Infants Fed a lower calorie formula with 2’FL show growth and 2’FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr. 2015;61:649-58.

Donovan SM, Comstock SS. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Ann Nutr Metab. 2016;69(2):42-51.

Legrand D. Overview of Lactoferrin as a Natural Immune Modulator. J Pediatr. 2016;173:S10-5.

Lönnerdal B. Lactoferrin in human milk: Its role in iron absorption and protection against enteric infections in the newborn infant. Arch Dis Child. 1980;55(6):417-21.

Sengupta AS, Lal A, Bhayana H. Effect of novel human milk oligosaccharides-based human milk fortifier containing lactoferrin, docosahexaenoic acid, and arachidonic acid on the growth of preterm infants with birth weight of 700-1800 g. Indian J Child Heal. 2024;10(11):142-4.

Dinleyici M, Barbieur J, Dinleyici EC, Vandenplas Y. Functional effects of human milk oligosaccharides (HMOs). Gut Microbes. 2023;15(1):2186115.